The expressions of UGT1A1 metabolic enzyme and nine transporters are decreased in NAFLD rats, indicating that the metabolism of the drug components absorbed into the blood was inhibited in the model group, and the drug uptake and excretion were also inhibited. Here, UGT1A1 is linked to metabolic dysfunction-associated steatotic liver disease.